{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T16:37:58Z","timestamp":1783787878192,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10692-w","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T08:28:31Z","timestamp":1754123311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Design, synthesis and bioactivity evaluation of phosphinanes as potential anticancer agents"],"prefix":"10.1038","volume":"15","author":[{"given":"El\u017cbieta","family":"\u0141astawiecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Strzyga-\u0141ach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Kiernozek-Kali\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Struga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bielenica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"10692_CR1","doi-asserted-by":"publisher","first-page":"7101","DOI":"10.1039\/C5RA25446A","volume":"6","author":"S Demkowicz","year":"2016","unstructured":"Demkowicz, S., Racho\u0144, J., Da\u015bko, M. & Kozak, W. Selected organophosphorus compounds with biological activity. Appl. Med. RSC Adv. 6, 7101\u20137112. https:\/\/doi.org\/10.1039\/C5RA25446A (2016).","journal-title":"Appl. Med. RSC Adv."},{"key":"10692_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/7081_2007_086","volume-title":"Bioactive Heterocycles II Topics in Heterocyclic Chemistry","author":"M Yamashita","year":"2007","unstructured":"Yamashita, M. Preparation, structure, and biological properties of phosphorus heterocycles with a C-P ring system. In Bioactive Heterocycles II Topics in Heterocyclic Chemistry (ed. Eguchi, S.) (Springer, 2007). https:\/\/doi.org\/10.1007\/7081_2007_086."},{"key":"10692_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.37871\/jbres1421","volume":"3","author":"PA Turhanen","year":"2022","unstructured":"Turhanen, P. A. Importance of organophosphorus compounds in medicinal chemistry field. J. Biomed. Res. Environ. Sci. 3, 195\u2013197. https:\/\/doi.org\/10.37871\/jbres1421 (2022).","journal-title":"J. Biomed. Res. Environ. Sci."},{"key":"10692_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202404258","volume":"9","author":"A Kumar","year":"2024","unstructured":"Kumar, A., Mukhopadhyay, J. & Bhagat, S. Phosphorus heterocycles and their biological applications. ChemistrySelect 9, e202404258. https:\/\/doi.org\/10.1002\/slct.202404258 (2024).","journal-title":"ChemistrySelect"},{"key":"10692_CR5","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1182\/blood-2004-05-1851","volume":"104","author":"T O'Hare","year":"2004","unstructured":"O\u2019Hare, T. et al. Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: Implications for CML. Blood 104, 2532\u20132539. https:\/\/doi.org\/10.1182\/blood-2004-05-1851 (2004).","journal-title":"Blood"},{"key":"10692_CR6","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1021\/acs.jmedchem.6b00306","volume":"59","author":"W-S Huang","year":"2016","unstructured":"Huang, W.-S. et al. Discovery of brigatinib (AP26113), a phosphine oxide-containing, potent, orally active inhibitor of anaplastic lymphoma kinase. J. Med. Chem. 59, 4948\u20134964. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00306 (2016).","journal-title":"J. Med. Chem."},{"key":"10692_CR7","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.1021\/acs.jmedchem.0c00407","volume":"63","author":"P Finkbeiner","year":"2020","unstructured":"Finkbeiner, P., Hehn, J. P. & Gnamm, C. Phosphine oxides from a medicinal chemist\u2019s perspective: Physicochemical and in vitro parameters relevant for drug discovery. J. Med. Chem. 63, 7081\u20137107. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00407 (2020).","journal-title":"J. Med. Chem."},{"key":"10692_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2020.100063","volume":"8","author":"H Yu","year":"2020","unstructured":"Yu, H., Yang, H., Shi, E. & Tang, W. Development and clinical application of phosphorus-containing drugs. Med. Drug Discov. 8, 100063. https:\/\/doi.org\/10.1016\/j.medidd.2020.100063 (2020).","journal-title":"Med. Drug Discov."},{"key":"10692_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.772418","volume":"12","author":"S Mitra","year":"2022","unstructured":"Mitra, S. et al. Anticancer applications and pharmacological properties of piperidine and piperine: A comprehensive review on molecular mechanisms and therapeutic perspectives. Front. Pharmacol. 12, 772418. https:\/\/doi.org\/10.3389\/fphar.2021.772418 (2022).","journal-title":"Front. Pharmacol."},{"key":"10692_CR10","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.bmcl.2013.12.114","volume":"24","author":"M Pal","year":"2014","unstructured":"Pal, M. & Bearne, S. L. Inhibition of glutamate racemase by substrate\u2013product analogues. Bioorg. Med. Chem. Lett. 24, 1432\u20131436. https:\/\/doi.org\/10.1016\/j.bmcl.2013.12.114 (2014).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10692_CR11","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1021\/acs.jmedchem.0c02072","volume":"64","author":"A-P Schaffner","year":"2021","unstructured":"Schaffner, A.-P. et al. Phosphinanes and azaphosphinanes as potent and selective inhibitors of activated thrombin-activatable fibrinolysis inhibitor (TAFIa). J. Med. Chem. 64, 3897\u20133910. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c02072 (2021).","journal-title":"J. Med. Chem."},{"key":"10692_CR12","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0968-0896(96)00121-6","volume":"4","author":"JW Darrow","year":"1996","unstructured":"Darrow, J. W. & Drueckhammer, D. G. A cyclic phosphonamidate analogue of glucose as a selective inhibitor of inverting glycosidases. Bioorg. Med. Chem. 4, 1341\u20131348. https:\/\/doi.org\/10.1016\/0968-0896(96)00121-6 (1996).","journal-title":"Bioorg. Med. Chem."},{"key":"10692_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1071\/CH9740801","volume":"27","author":"LE Rowley","year":"1974","unstructured":"Rowley, L. E. & Swan, J. M. Organophosphorus compounds. X. A new synthesis of 1,2,3,4-tetrahydrophosphinolines. Aust. J. Chem. 27, 801\u2013813. https:\/\/doi.org\/10.1071\/CH9740801 (1974).","journal-title":"Aust. J. Chem."},{"key":"10692_CR14","unstructured":"Cho, A. et al. Inhibitors of Flaviviridae viruses. WO2011031669A1 (2011)."},{"key":"10692_CR15","unstructured":"Maurice, T. et al. Novel phosphinolactone derivatives and pharmaceutical uses thereof. US2019144476A1 (2019)."},{"key":"10692_CR16","unstructured":"Zhang, Y. et al. Sos1-inhibitor mit Phosphor. EP4148056A1 (2023)."},{"key":"10692_CR17","unstructured":"Zhang, J. et al. Cdk7 inhibitors and methods of treating cancer. WO2023049691A1 (2023)."},{"key":"10692_CR18","unstructured":"Shiraishi, M. et al. Anilide derivative, production and use thereof. US6166006A (2000)."},{"key":"10692_CR19","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1248\/cpb.52.818","volume":"52","author":"M Seto","year":"2004","unstructured":"Seto, M. et al. Orally active CCR5 antagonists as anti-HIV-1 agents 2: Synthesis and biological activities of anilide derivatives containing a pyridine N-oxide moiety. Chem. Pharm. Bull. 52, 818\u2013829. https:\/\/doi.org\/10.1248\/cpb.52.818 (2004).","journal-title":"Chem. Pharm. Bull."},{"key":"10692_CR20","unstructured":"Nishimura, O. et al. Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative. US6268354B1 (2001)."},{"key":"10692_CR21","unstructured":"Wester, R. T. Phosphorus containing renin inhibitors. US5468732A (1995)."},{"key":"10692_CR22","unstructured":"Bridges, A. Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels. US20050143349A1 (2005)."},{"key":"10692_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1515\/HC.2009.15.4.273","volume":"15","author":"M Fujie","year":"2009","unstructured":"Fujie, M. et al. A novel phospha sugar analogue: Synthesis and evaluation of 2,3-dibromo-3-methyl-1-phenylphospholane 1-oxide as a new class of potential anti-proliferative materials for leukemia cells. Heterocycl. Commun. 15, 273\u2013278. https:\/\/doi.org\/10.1515\/HC.2009.15.4.273 (2009).","journal-title":"Heterocycl. Commun."},{"key":"10692_CR24","unstructured":"Shibata, K. et al. Small molecule inhibitors of KRAS G12C mutant. WO2022232318A1 (2022)."},{"key":"10692_CR25","unstructured":"Jankowski, O. D., Palmer, J. T. & Honigberg, L. Inhibitors of tyrosine kinases and uses thereof. WO2007087068A2 (2007)."},{"key":"10692_CR26","unstructured":"Aquila, B. et al. Chemical compounds. US2012028924A1 (2012)."},{"key":"10692_CR27","doi-asserted-by":"publisher","first-page":"7496","DOI":"10.1016\/j.bmcl.2011.09.113","volume":"21","author":"JC Lanter","year":"2011","unstructured":"Lanter, J. C. et al. The discovery of novel cyclohexylamide CCR2 antagonists. Bioorg. Med. Chem. Lett. 21, 7496\u20137501. https:\/\/doi.org\/10.1016\/j.bmcl.2011.09.113 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10692_CR28","unstructured":"Gill, A. L. et al. Bicyclic heteroaryl compounds and uses thereof. US2021139517A1 (2021)."},{"key":"10692_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.dyepig.2022.110201","volume":"201","author":"X Lin","year":"2022","unstructured":"Lin, X. et al. Phosphorus-substituted rhodamines for bioimaging of the lysosomal peroxynitrite in vivo. Dyes Pigments 201, 110201. https:\/\/doi.org\/10.1016\/j.dyepig.2022.110201 (2022).","journal-title":"Dyes Pigments"},{"key":"10692_CR30","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1039\/D0OB00043D","volume":"18","author":"L Lesiak","year":"2020","unstructured":"Lesiak, L. et al. Imaging GPCR internalization using near-infrared Nebraska Red-based reagents. Org. Biomol. Chem. 18, 2459\u20132467. https:\/\/doi.org\/10.1039\/D0OB00043D (2020).","journal-title":"Org. Biomol. Chem."},{"key":"10692_CR31","doi-asserted-by":"publisher","first-page":"14506","DOI":"10.1002\/chem.201802875","volume":"24","author":"X Chai","year":"2018","unstructured":"Chai, X. et al. Bridge-caging strategy in phosphorus-substituted rhodamine for modular development of near-infrared fluorescent probes. Chem. Eur. J. 24, 14506\u201314512. https:\/\/doi.org\/10.1002\/chem.201802875 (2018).","journal-title":"Chem. Eur. J."},{"key":"10692_CR32","unstructured":"McCarthy Cole, B. & Ellis, J. L. Phosphonium Ion Channel Blockers and Methods for Use. US11618761B2 (2023)."},{"key":"10692_CR33","unstructured":"McCarthy Cole, B. & Ellis, J. L. Phosphonium Ion Channel Blockers and Methods for Use. US20210128589A1 (2021)."},{"key":"10692_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/03086648008078209","volume":"8","author":"R Fink","year":"1980","unstructured":"Fink, R., Van Der Helm, D. & Berlin, K. D. Carbon-Phosphorus Heterocycles. Structural Analysis of 1,2,3,4-Tetrahydro-1,4-Dimethyl-1-Phenyl-Phosphinolinium Hexafluorophosphate and 1,2,3,4-Tetrahydro-1-Ethyl-4-Methyl-1-Phenylphosphinolinium Hexafluorophosphate. A Novel Cocrystallization of Stereoisomers of the Former. Phosphorus Sulfur. Relat. Elem. 8, 325\u2013330. https:\/\/doi.org\/10.1080\/03086648008078209 (1980).","journal-title":"Phosphorus Sulfur. Relat. Elem."},{"key":"10692_CR35","unstructured":"Holmes, I. et al. Anti-bacterial compounds. WO2017093543A2 (2017)."},{"key":"10692_CR36","unstructured":"Romero-Nieto, C., R\u00f6sch, S., Herold-Mende, C. & Fermi, V. Phosphaphenalene-Gold(I) Complexes as Chemotherapeutic Agents Against Glioblastoma. WO2022079085A1 (2022)."},{"key":"10692_CR37","doi-asserted-by":"publisher","first-page":"14593","DOI":"10.1039\/D0CC05761D","volume":"56","author":"S Roesch","year":"2020","unstructured":"Roesch, S., Fermi, V., Rominger, F., Herold-Mende, C. & Romero-Nieto, C. Gold(I) complexes based on six-membered phosphorus heterocycles as bio-active molecules against brain cancer. Chem. Commun. 56, 14593\u201314596. https:\/\/doi.org\/10.1039\/D0CC05761D (2020).","journal-title":"Chem. Commun."},{"key":"10692_CR38","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.1016\/j.tet.2017.07.004","volume":"73","author":"E Korzeniowska","year":"2017","unstructured":"Korzeniowska, E., Kozio\u0142, A. E., \u0141astawiecka, E., Flis, A. & Stankevi\u010d, M. The reactivity of arylphosphine oxides under bouveault-blanc reaction conditions. Tetrahedron 73, 5153\u20135162. https:\/\/doi.org\/10.1016\/j.tet.2017.07.004 (2017).","journal-title":"Tetrahedron"},{"key":"10692_CR39","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.1016\/j.tet.2011.09.045","volume":"67","author":"M Stankevi\u010d","year":"2011","unstructured":"Stankevi\u010d, M., W\u0142odarczyk, A., Jakli\u0144ska, M., Parcheta, R. & Pietrusiewicz, K. M. Sodium in liquid ammonia\u2013A Versatile tool in modifications of arylphosphine oxides. Tetrahedron 67, 8671\u20138678. https:\/\/doi.org\/10.1016\/j.tet.2011.09.045 (2011).","journal-title":"Tetrahedron"},{"key":"10692_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/ejoc.201200096","author":"M Stankevi\u010d","year":"2012","unstructured":"Stankevi\u010d, M., W\u00f3jcik, K., Jakli\u0144ska, M. & Pietrusiewicz, K. M. In situ dearomatisation\/alkylation of arylphosphane derivatives. Eur. J. Org. Chem. https:\/\/doi.org\/10.1002\/ejoc.201200096 (2012).","journal-title":"Eur. J. Org. Chem."},{"key":"10692_CR41","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1261\/rna.990208","volume":"14","author":"J Kowalska","year":"2008","unstructured":"Kowalska, J. et al. Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS. RNA 14, 1119\u20131131. https:\/\/doi.org\/10.1261\/rna.990208 (2008).","journal-title":"RNA"},{"key":"10692_CR42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.antiviral.2013.02.014","volume":"98","author":"MA Cheek","year":"2013","unstructured":"Cheek, M. A., Sharaf, M. L., Dobrikov, M. I. & Shaw, B. R. Inhibition of hepatitis C viral RNA-dependent RNA polymerase by \u03b1-P-boranophosphate Nucleotides: Exploring a potential strategy for mechanism-based HCV drug design. Antiviral Res. 98, 144\u2013152. https:\/\/doi.org\/10.1016\/j.antiviral.2013.02.014 (2013).","journal-title":"Antiviral Res."},{"key":"10692_CR43","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3390\/ijms21051826","volume":"21","author":"J Depciuch","year":"2020","unstructured":"Depciuch, J. et al. Similarities in the general chemical composition of colon cancer cells and their microvesicles investigated by spectroscopic methods-potential clinical relevance. Int. J. Mol. Sci. 21, 1826. https:\/\/doi.org\/10.3390\/ijms21051826 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"10692_CR44","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1002\/chem.200802307","volume":"15","author":"M Hurtado","year":"2009","unstructured":"Hurtado, M. et al. The ever-surprising chemistry of boron: enhanced acidity of phosphine\u22c5boranes. Chem. Eur. J. 15, 4622\u20134629. https:\/\/doi.org\/10.1002\/chem.200802307 (2009).","journal-title":"Chem. Eur. J."},{"key":"10692_CR45","volume-title":"A Guide to Organophosphorus Chemistry","author":"LD Quin","year":"2000","unstructured":"Quin, L. D. A Guide to Organophosphorus Chemistry (Wiley, 2000)."},{"key":"10692_CR46","volume-title":"International Tables for Crystallography. Volume C Mathematical Physical and Chemical Tables","author":"AJC Wilson","year":"1992","unstructured":"Wilson, A. J. C. & Geist, V. International Tables for Crystallography. Volume C Mathematical Physical and Chemical Tables (Kluwer Academic Publishers, 1992)."},{"key":"10692_CR47","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka, T., Narazaki, M. & Kishimoto, T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb. Perspect. Biol. 6, a016295. https:\/\/doi.org\/10.1101\/cshperspect.a016295 (2014).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10692_CR48","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.anai.2022.10.025","volume":"130","author":"EY Lee","year":"2023","unstructured":"Lee, E. Y. & Jakubovic, B. D. Interleukin-6 and cytokine release syndrome: A new understanding in drug hypersensitivity reactions. Ann. Allergy Asthma Immunol. 130, 178\u2013184. https:\/\/doi.org\/10.1016\/j.anai.2022.10.025 (2023).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10692_CR49","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.7150\/ijbs.4614","volume":"8","author":"MJ Waldner","year":"2012","unstructured":"Waldner, M. J., Foersch, S. & Neurath, M. F. Interleukin-6\u2014A key regulator of colorectal cancer development. Int. J. Biol. Sci. 8, 1248\u20131253. https:\/\/doi.org\/10.7150\/ijbs.4614 (2012).","journal-title":"Int. J. Biol. Sci."},{"key":"10692_CR50","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/bjc.2013.748","volume":"110","author":"T Nagasaki","year":"2014","unstructured":"Nagasaki, T. et al. Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: Anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction. Br. J. Cancer 110, 469\u2013478. https:\/\/doi.org\/10.1038\/bjc.2013.748 (2014).","journal-title":"Br. J. Cancer"},{"key":"10692_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00384-009-0818-8","volume":"25","author":"H Kn\u00fcpfer","year":"2010","unstructured":"Kn\u00fcpfer, H. & Preiss, R. Serum interleukin-6 levels in colorectal cancer patients\u2014A summary of published results. Int. J. Colorectal Dis. 25, 135\u2013140. https:\/\/doi.org\/10.1007\/s00384-009-0818-8 (2010).","journal-title":"Int. J. Colorectal Dis."},{"key":"10692_CR52","doi-asserted-by":"publisher","unstructured":"Rose-John, S. Interleukin-6 Signalling in Health and Disease. F1000Research 9, F1000 Faculty Rev-1013 (2020). https:\/\/doi.org\/10.12688\/f1000research.26058.1.","DOI":"10.12688\/f1000research.26058.1"},{"key":"10692_CR53","doi-asserted-by":"publisher","first-page":"9774","DOI":"10.1021\/acs.joc.5b01476","volume":"80","author":"AM Gregson","year":"2015","unstructured":"Gregson, A. M., Wales, S. M., Bailey, S. J., Willis, A. C. & Keller, P. A. Cyclic phosphine oxides and phosphinamides from Di-grignard reagents and phosphonic dichlorides: Modular access to annulated phospholanes. J. Org. Chem. 80, 9774\u20139780. https:\/\/doi.org\/10.1021\/acs.joc.5b01476 (2015).","journal-title":"J. Org. Chem."},{"key":"10692_CR54","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.1021\/acs.joc.0c03055","volume":"86","author":"E \u0141astawiecka","year":"2021","unstructured":"\u0141astawiecka, E., Frynas, S. & Pietrusiewicz, K. M. Desymmetrization approach to the synthesis of optically active P-stereogenic phosphin-2-en-4-ones. J. Org. Chem. 86, 6195\u20136206. https:\/\/doi.org\/10.1021\/acs.joc.0c03055 (2021).","journal-title":"J. Org. Chem."},{"key":"10692_CR55","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/omr.1270210602","volume":"21","author":"KM Pietrusiewicz","year":"1983","unstructured":"Pietrusiewicz, K. M. 13C and 31P NMR studies of configurational and conformational effects in 1-Phenyl-4-phosphorinanones and their 1-selenides. Org. Magn. Reson. 21, 345\u2013351. https:\/\/doi.org\/10.1002\/omr.1270210602 (1983).","journal-title":"Org. Magn. Reson."},{"key":"10692_CR56","unstructured":"Agilent Technologies Inc. (2014) Yarnton, UK"},{"key":"10692_CR57","unstructured":"CrysAlisPro 1.171.42.79a (2022) Rigaku Oxford Diffraction, Tokio, Japan."},{"issue":"Pt 1","key":"10692_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S2053273314026370","volume":"71","author":"GM Sheldrick","year":"2015","unstructured":"Sheldrick, G. M. SHELXT\u2014Integrated space-group and crystal-structure determination. Acta Crystallogr. A Found. Adv. 71(Pt 1), 3\u20138. https:\/\/doi.org\/10.1107\/S2053273314026370 (2015).","journal-title":"Acta Crystallogr. A Found. Adv."},{"key":"10692_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S2053229614024218","volume":"71","author":"GM Sheldrick","year":"2015","unstructured":"Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. C Struct. Chem. 71, 3\u20138. https:\/\/doi.org\/10.1107\/S2053229614024218 (2015).","journal-title":"Acta Crystallogr. C Struct. Chem."},{"key":"10692_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1107\/S0108767307043930","volume":"64","author":"GM Sheldrick","year":"2008","unstructured":"Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. A Found. Adv. 64, 112\u2013122. https:\/\/doi.org\/10.1107\/S0108767307043930 (2008).","journal-title":"Acta Crystallogr. A Found. Adv."},{"key":"10692_CR61","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3390\/ph14111097","volume":"14","author":"P Strzyga-\u0141ach","year":"2021","unstructured":"Strzyga-\u0141ach, P., Chrzanowska, A., Podsadni, K. & Bielenica, A. Investigation of the mechanisms of cytotoxic activity of 1,3-disubstituted thiourea derivatives. Pharmaceuticals 14, 1097. https:\/\/doi.org\/10.3390\/ph14111097 (2021).","journal-title":"Pharmaceuticals"},{"key":"10692_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111810","volume":"185","author":"A Chrzanowska","year":"2020","unstructured":"Chrzanowska, A. et al. Anticancer and antimicrobial effects of novel ciprofloxacin fatty acids conjugates. Eur. J. Med. Chem. 185, 111810. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111810 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"10692_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202300105","volume":"356","author":"P Strzyga-\u0141ach","year":"2023","unstructured":"Strzyga-\u0141ach, P. et al. Proapoptotic effects of halogenated bis-phenylthiourea derivatives in cancer cells. Arch. Pharm. (Weinheim) 356, e2300105. https:\/\/doi.org\/10.1002\/ardp.202300105 (2023).","journal-title":"Arch. Pharm. (Weinheim)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10692-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10692-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10692-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T10:03:38Z","timestamp":1754388218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10692-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10692"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10692-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28229"}}